1. Home
  2. COMM vs ARQT Comparison

COMM vs ARQT Comparison

Compare COMM & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CommScope Holding Company Inc.

COMM

CommScope Holding Company Inc.

HOLD

Current Price

$17.95

Market Cap

4.2B

Sector

Technology

ML Signal

HOLD

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$27.79

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COMM
ARQT
Founded
1976
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
3.3B
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
COMM
ARQT
Price
$17.95
$27.79
Analyst Decision
Hold
Strong Buy
Analyst Count
5
7
Target Price
$13.25
$24.83
AVG Volume (30 Days)
4.7M
2.1M
Earning Date
10-30-2025
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
3.52
N/A
Revenue
$5,299,100,000.00
$317,929,000.00
Revenue This Year
$37.00
$85.51
Revenue Next Year
$7.36
$30.74
P/E Ratio
$5.05
N/A
Revenue Growth
33.82
129.21
52 Week Low
$2.94
$11.13
52 Week High
$20.55
$31.77

Technical Indicators

Market Signals
Indicator
COMM
ARQT
Relative Strength Index (RSI) 45.62 47.41
Support Level $17.62 $28.30
Resistance Level $20.61 $31.77
Average True Range (ATR) 0.77 1.14
MACD -0.30 -0.57
Stochastic Oscillator 11.02 5.80

Price Performance

Historical Comparison
COMM
ARQT

About COMM CommScope Holding Company Inc.

CommScope Holding Co Inc is a provider of infrastructure solutions for communication, data center, and entertainment networks. The company provides solutions for wired and wireless networks to enable service providers, including cable, telephone, data center, and digital broadcast satellite operators and media programmers, to deliver media, voice, Internet Protocol (IP) data services, and Wi-Fi to their subscribers and allow enterprises to experience constant wireless and wired connectivity across complex and varied networking environments. The company's operating segments are: Connectivity and Cable Solutions (CCS), Networking, Intelligent Cellular and Security Solutions (NICS), and Access Network Solutions (ANS).

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

Share on Social Networks: